Skip to main content
Erschienen in: Obesity Surgery 5/2008

01.05.2008 | Research Article

A Prospective Multicenter Study of 163 Sleeve Gastrectomies: Results at 1 and 2 Years

verfasst von: D. Nocca, D. Krawczykowsky, B. Bomans, P. Noël, M. C. Picot, P. M. Blanc, C. de Seguin de Hons, B. Millat, M. Gagner, L. Monnier, J. M. Fabre

Erschienen in: Obesity Surgery | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Good results obtained after laparoscopic sleeve gastrectomy (LSG), in terms of weight loss and morbidity, have been reported in few recent studies. Our team has designed a multicenter prospective study for the evaluation of the effectiveness and feasibility of this operation as a restrictive procedure.

Methods

From January 2003 to September 2006, 163 patients (68% women) with an average age of 41.57 years, were operated on with a LSG. Indications for this procedure were morbid obese [body mass index (BMI) > 40 kg/m2] or severe obese patients (BMI > 35 kg/m2) with severe comorbidities (diabetes, sleep apnea, hypertension…) with high-volume eating disorders and superobese patients (BMI > 50 kg/m2).

Results

The average BMI was 45.9 kg/m2. Forty-four patients (26.99%) were superobese, 84 (51.53%) presented with morbid obesity, and 35 (21.47%) were severe obese patients. Prospective evaluations of excess weight loss, mortality, and morbidity have been analyzed. Laparoscopy was performed in 162 cases (99.39%). No conversion to laparotomy had to be performed. There was no operative mortality. Perioperative complications occurred in 12 cases (7.36%). The reoperation rate was 4.90% and the postoperative morbidity was 6.74% due to six gastric fistulas (3.66%), in which four patients (2.44%) had a previous laparoscopic adjustable gastric banding. Long-term morbidity was caused by esophageal reflux symptoms (11.80%). The percentage of loss in excessive body weight was 48.97% at 6 months, 59.45% at 1 year (120 patients), 62.02% at 18 months, and 61.52% at 2 years (98 patients). No statistical difference was noticed in weight loss between obese and extreme obese patients.

Conclusions

The sleeve gastrectomy seems to be a safe and effective restrictive bariatric procedure to treat morbid obesity in selected patients. LSG may be proposed for volume-eater patients or to prepare superobese patients for laparoscopic gastric bypass or laparoscopic duodenal switch. However, weight regained, quality of life, and evolution of morbidities due to obesity need to be evaluated in a long-term follow up.
Literatur
1.
Zurück zum Zitat Marceau P, Hould F-S, et al. Biliopancreatic diversion with duodénal switch. World J Surg. 1998;22:947–54.PubMedCrossRef Marceau P, Hould F-S, et al. Biliopancreatic diversion with duodénal switch. World J Surg. 1998;22:947–54.PubMedCrossRef
2.
Zurück zum Zitat Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.PubMedCrossRef Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.PubMedCrossRef
3.
Zurück zum Zitat Silecchia G, Boru C, Pecchia A, Rizzello M, Casella G, Leonetti F, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16(9):1138–44.PubMedCrossRef Silecchia G, Boru C, Pecchia A, Rizzello M, Casella G, Leonetti F, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16(9):1138–44.PubMedCrossRef
4.
Zurück zum Zitat Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20(6):859–63.PubMedCrossRef Cottam D, Qureshi FG, Mattar SG, Sharma S, Holover S, Bonanomi G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20(6):859–63.PubMedCrossRef
5.
Zurück zum Zitat Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006;16(11):1445–9.PubMedCrossRef Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006;16(11):1445–9.PubMedCrossRef
6.
Zurück zum Zitat Himpens J, Dapri G, Cadiere GB. A prospective randomised study between laparoscopic adjustable gastric bandind and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRef Himpens J, Dapri G, Cadiere GB. A prospective randomised study between laparoscopic adjustable gastric bandind and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRef
7.
Zurück zum Zitat Han SM, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.CrossRef Han SM, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.CrossRef
8.
Zurück zum Zitat Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.PubMedCrossRef Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16(10):1323–6.PubMedCrossRef
9.
Zurück zum Zitat Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14:492–7.PubMedCrossRef Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg. 2004;14:492–7.PubMedCrossRef
10.
Zurück zum Zitat Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes Surg. 2005;15:612–7.PubMedCrossRef Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes Surg. 2005;15:612–7.PubMedCrossRef
11.
Zurück zum Zitat Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030–3.PubMedCrossRef Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030–3.PubMedCrossRef
12.
Zurück zum Zitat MacLean LD, Rhode BM, Forse RA, Nohr C. Surgery for obesity. An update of a randomized trial. Obes Surg. 1995;5:145–53.PubMedCrossRef MacLean LD, Rhode BM, Forse RA, Nohr C. Surgery for obesity. An update of a randomized trial. Obes Surg. 1995;5:145–53.PubMedCrossRef
13.
Zurück zum Zitat Forsell P, et al. A gastric band with adjustable inner diameter for obesity surgery. Obes Surg. 1993;3:303–6.PubMedCrossRef Forsell P, et al. A gastric band with adjustable inner diameter for obesity surgery. Obes Surg. 1993;3:303–6.PubMedCrossRef
14.
Zurück zum Zitat Forsell P, Hellers G, Hell E. The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity—weight loss, complications, pouch volume, and stoma diameter in a four-year follow-up. Acta Chir Aust. 1998;30:161–5.CrossRef Forsell P, Hellers G, Hell E. The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity—weight loss, complications, pouch volume, and stoma diameter in a four-year follow-up. Acta Chir Aust. 1998;30:161–5.CrossRef
15.
Zurück zum Zitat Nocca D, Aggarwal R, Blanc P, Gallix B, Di Mauro GL, Millat B, et al. Laparoscopic vertical banded gastroplasty: a multicenter prospective study of 200 procedures. Surg Endosc. 2007;21:870–4.PubMedCrossRef Nocca D, Aggarwal R, Blanc P, Gallix B, Di Mauro GL, Millat B, et al. Laparoscopic vertical banded gastroplasty: a multicenter prospective study of 200 procedures. Surg Endosc. 2007;21:870–4.PubMedCrossRef
16.
Zurück zum Zitat Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.PubMedCrossRef Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024–9.PubMedCrossRef
17.
Zurück zum Zitat Ueda K, Gagner M, Milone L, Bardaro SJ, Gong K. Sleeve gastrectomy with wrapping using polytetrafluoroethylene to prevent gastric enlargement in a porcine model. Surg Obes Relat Dis. 2007 March 30; [Epub ahead of print]. Ueda K, Gagner M, Milone L, Bardaro SJ, Gong K. Sleeve gastrectomy with wrapping using polytetrafluoroethylene to prevent gastric enlargement in a porcine model. Surg Obes Relat Dis. 2007 March 30; [Epub ahead of print].
18.
Zurück zum Zitat Consten EC, Gagner M, Pomp A, Inabnet WB. Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg. 2004;14:1360–6.PubMedCrossRef Consten EC, Gagner M, Pomp A, Inabnet WB. Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane. Obes Surg. 2004;14:1360–6.PubMedCrossRef
Metadaten
Titel
A Prospective Multicenter Study of 163 Sleeve Gastrectomies: Results at 1 and 2 Years
verfasst von
D. Nocca
D. Krawczykowsky
B. Bomans
P. Noël
M. C. Picot
P. M. Blanc
C. de Seguin de Hons
B. Millat
M. Gagner
L. Monnier
J. M. Fabre
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 5/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9288-7

Weitere Artikel der Ausgabe 5/2008

Obesity Surgery 5/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.